KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Interest Coverage Ratio (2016 - 2025)

Emergent BioSolutions (EBS) has 15 years of Interest Coverage Ratio data on record, last reported at 1.9 in Q4 2025.

  • For Q4 2025, Interest Coverage Ratio fell 195.68% year-over-year to 1.9; the TTM value through Dec 2025 reached 1.69, up 210.26%, while the annual FY2025 figure was 1.69, 210.26% up from the prior year.
  • Interest Coverage Ratio reached 1.9 in Q4 2025 per EBS's latest filing, down from 5.03 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 29.58 in Q4 2021 and bottomed at 12.29 in Q3 2023.
  • Average Interest Coverage Ratio over 5 years is 0.42, with a median of 1.27 recorded in 2025.
  • Peak YoY movement for Interest Coverage Ratio: soared 904.18% in 2021, then crashed 1156.49% in 2023.
  • A 5-year view of Interest Coverage Ratio shows it stood at 29.58 in 2021, then plummeted by 116.48% to 4.88 in 2022, then surged by 58.6% to 2.02 in 2023, then soared by 68.2% to 0.64 in 2024, then plummeted by 195.68% to 1.9 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 1.9 in Q4 2025, 5.03 in Q3 2025, and 0.11 in Q2 2025.